Allergan pays $750M to settle Namenda 'hard switch' suit by Angus Liu Monday, October 28, 2019 The suit alleged Allergan tried to pull Namenda off the market right before patent expiration to force patients onto its long-acting version.
With generics looming, Pfizer wins FDA nod for longer-acting Lyrica by Eric Sagonowsky Thursday, October 12, 2017 Bracing for generic competition to big-selling Lyrica, Pfizer has won FDA approval for a longer-lasting version that could help it defend sales.
